TALIS BIOMEDICAL CORP (TLIS) Stock Balance Sheet
NASDAQ:TLIS - Nasdaq - US87424L2079 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 59.87M | 76.73M | 130.19M | 232.54M | 138.48M | |||
| Receivables | 0.00 | 50.00K | 308.00K | 183.00K | 471.00K | |||
| Other Current Assets | 3.73M | 901.00K | 2.78M | 3.39M | 49.77M | |||
| Total Current Assets | 63.60M | 77.68M | 133.28M | 236.12M | 188.72M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.33M | 15.45M | 34.23M | 23.43M | 9.68M | |||
| Other Non-Current Assets | 766.00K | 1.54M | 1.78M | 6.28M | 0.00 | |||
| Total Non-Current Assets | 9.10M | 16.99M | 36.01M | 29.71M | 9.68M | |||
| TOTAL ASSETS | 72.70M | 94.67M | 169.29M | 265.83M | 198.41M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 4.41M | 7.43M | 8.90M | 12.90M | 10.40M | |||
| Accounts Payable | 3.79M | 1.34M | 3.77M | 5.12M | 4.91M | |||
| Other Current Liabilities | N/A | N/A | N/A | 1.08M | 721.00K | |||
| Total Current Liabilities | 8.20M | 8.77M | 12.67M | 19.11M | 16.03M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 15.88M | 16.79M | 29.88M | 12.74M | 5.00K | |||
| Total Non-Current Liabilities | 15.88M | 16.79M | 29.88M | 12.74M | 5.00K | |||
| TOTAL LIABILITIES | 24.07M | 25.56M | 42.55M | 31.85M | 16.03M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -561.85M | -539.96M | -477.95M | -364.94M | -172.91M | |||
| Additional Paid In Capital | 610.47M | 609.07M | 604.69M | 598.91M | 64.33M | |||
| Common Shares | 3.18K | 3.00K | 6.00K | 6.00K | 290.94M | |||
| Other Shareholders' Equity | -180.00 | 0.00 | N/A | N/A | N/A | |||
| Shares Outstanding | 1.82M | 1.82M | 1.79M | 1.76M | 1.56M | |||
| Tangible Book Value per Share | 26.68 | 37.93 | 70.96 | 132.86 | -69.37 | |||
| Total Shareholders' Equity | 48.63M | 69.12M | 126.74M | 233.98M | 182.37M | |||
| TOTAL LIABILITIES AND EQUITY | 72.70M | 94.67M | 169.29M | 265.83M | 198.41M | |||
| Statistics | ||||||||
| Current Ratio | 7.76 | 8.86 | 10.52 | 12.36 | 11.78 | |||
| Return On Assets (ROA) | -70.19% | -65.50% | -66.76% | -72.24% | -45.93% | |||
| Return On Equity (ROE) | -104.94% | -89.71% | -89.17% | -82.07% | -49.97% | |||
All data in USD , ROIC based on taxRate of 0.21